Erik Kock

993 citations
24 papers · 737 indexed · h-index 15
Topics
Ocular Oncology and Treatments (16 papers)Glaucoma and retinal disorders (6 papers)Brain Metastases and Treatment (4 papers)

In The Last Decade

Erik Kock

23 papers receiving 671 citations

Peers

Erik Kock
Comparison fields: 5 of 72
  • Ophthalmology 608
  • Radiology, Nuclear Medicine and Imaging 236
  • Oncology 223
  • Molecular Biology 156
  • Epidemiology 118
Replace Jerry A. Shields with:
Jerry A. Shields United States
Vitaliano B. Bernardino United States
Carol L. Shields United States
Kimberly J. Chin United States
E. Rand Simpson Canada
Jorge E. Freire United States
Jean‐Daniel Grange France
Sanket U. Shah United States
Shields Ja United States
Saad Al-Dahmash Saudi Arabia
Erik Kock relative to Jerry A. Shields United States Jerry A. Shields's profile →
Citations per field
00.5×1.5×2.5×
Jerry A. Shields · 1×
Citations per year

Countries citing papers authored by Erik Kock

Since Specialization
Citations

This map shows the geographic impact of Erik Kock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Kock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Kock more than expected).

Fields of papers citing papers by Erik Kock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Kock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Kock. The network helps show where Erik Kock may publish in the future.

Co-authorship network of co-authors of Erik Kock

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Kock. A scholar is included among the top collaborators of Erik Kock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Kock. Erik Kock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 20
2 61
3 18
4 37
5 2
6 2
7 12
8 85
9 15
10 17
11 12
12 98
13 22
14 6
15 11
16 19
17 65
18 0
19 6
20 82

About Erik Kock

Erik Kock is a scholar working on Ophthalmology, Dermatology and Cell Biology, having authored 24 papers that have together received 737 indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (16 papers), Glaucoma and retinal disorders (6 papers) and Brain Metastases and Treatment (4 papers). The work is most often cited by research in Ophthalmology (608 citations), Radiology, Nuclear Medicine and Imaging (236 citations) and Oncology (223 citations). Erik Kock has collaborated with scholars based in Sweden, Norway and United Kingdom. Frequent co-authors include Stefan Seregard, Peep V. Algvere, Eva af Trampe, Ingmar Lax, G. E. F. Lundell, Magnus Nordenskjöld, Robert S. Sparkes, William F. Benedict, Webster K. Cavenee and A. Linn Murphree. Their work appears in journals such as New England Journal of Medicine, Ophthalmology and American Journal of Ophthalmology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026